Immunogenicity and Safety Study of SCB-2019 Vaccine as a Booster to COVID-19 Vaccine in Adults

NCT05188677 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1831

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: Candidate vaccine, SCB-2019
BIOLOGICAL: Comirnaty Vaccine
BIOLOGICAL: Vaxzevria Vaccine
BIOLOGICAL: CoronaVac Vaccine

Sponsor

Clover Biopharmaceuticals AUS Pty